GLOW
A triple-peptide combination of BPC-157, TB-500, and GHK-Cu targeting complementary angiogenic, cellular migration, and extracellular matrix remodeling pathways in preclinical research.
Third-party tested, batch-by-batch
Every lot is independently verified for identity (MS), purity (HPLC), appearance, and endotoxin. View the summary for the current lot, or request the full signed PDF by email.
Frequently researched together
Technical specifications
GLOW is a lyophilized research blend combining three peptide compounds that have been independently studied in preclinical models. BPC-157 is a 15-amino acid synthetic pentadecapeptide whose sequence is derived from a gastroprotective protein fraction; it has been investigated in cell culture and animal models for effects on angiogenic signaling, nitric oxide pathways, and cytoprotection. TB-500 is a synthetic analogue of Thymosin Beta-4 (Tβ4), an endogenous 43-amino acid peptide that regulates actin sequestration via G-actin binding; Tβ4 has been studied for roles in cellular migration, wound healing, and angiogenesis in preclinical models. GHK-Cu is a naturally occurring copper-chelating tripeptide studied for extracellular matrix remodeling and gene expression modulation in fibroblast systems. This combination is formulated as a lyophilized powder for in vitro and preclinical laboratory research only; each component targets complementary pathways in tissue biology research.
- BPC-157: synthetic 15-AA pentadecapeptide; investigated in rodent wound and gastroprotection models for angiogenic effects via VEGFR2 and FAK–paxillin signaling
- TB-500 (Tβ4): binds G-actin with high affinity (Kd ~0.5 µM), sequestering monomeric actin and modulating cytoskeletal dynamics in cell migration assays
- Thymosin Beta-4 is naturally expressed in most nucleated cells at high concentration; the synthetic analogue TB-500 mimics its actin-binding domain for research use
- GHK-Cu chelates Cu²⁺ with a formation constant of ~10¹⁶ M⁻¹ and has been studied for modulation of collagen, elastin, and glycosaminoglycan synthesis in fibroblast models
- All three components are independently studied in published preclinical literature; combination effects in this formulation have not been studied in controlled published trials
- Lyophilized blend; reconstitute with bacteriostatic water for in vitro use only
- For research use only — not for human or veterinary administration
Peer-reviewed research
All products sold by Next Level Research LLC are intended for laboratory and research use only. Not for human or animal consumption. Not a drug, food, or cosmetic. No therapeutic claims are made.